348
Views
5
CrossRef citations to date
0
Altmetric
CLINICAL FOCUS: Diabetes   Original Research

Atorvastatin counteracts high glucose-induced Krüppel-like factor 2 suppression in human umbilical vein endothelial cells

, , , , &
Pages 446-454 | Received 22 Nov 2014, Accepted 07 Apr 2015, Published online: 30 Apr 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Yueshan Fan, Dong Wang, Chenxu Rao, Ying Li, Hongtao Rong, Zengguang Wang & Jianning Zhang. (2020) Atorvastatin Combined with Low-Dose Dexamethasone Treatment Protects Endothelial Function Impaired by Chronic Subdural Hematoma via the Transcription Factor KLF-2. Drug Design, Development and Therapy 14, pages 3291-3299.
Read now

Articles from other publishers (4)

Hongfan Zhao, Dashan Wu, Michael Adu Gyamfi, Pinchao Wang, Christian Luecht, Anna Maria Pfefferkorn, Muhammad Imtiaz Ashraf, Julian Kamhieh-Milz, Janusz Witowski, Duska Dragun, Klemens Budde, Ralf Schindler, Daniel Zickler, Guido Moll & Rusan Catar. (2023) Expanded Hemodialysis ameliorates uremia-induced impairment of vasculoprotective KLF2 and concomitant proinflammatory priming of endothelial cells through an ERK/AP1/cFOS-dependent mechanism. Frontiers in Immunology 14.
Crossref
Yibin Meng, Youhan Wang, Yibing li, Song Chon & Dingjun Hao. (2020) Overview of Therapeutic Effects of Statins on Inflammatory Diseases Through Regulating Adhesive Molecules. Current Stem Cell Research & Therapy 15:7, pages 614-622.
Crossref
Ziyang Zhang, Wenpei Chen, Yandong Wang, Tianqin Xiong, Chenghao Zhou, Xiaolan Yao & Baoqin Lin. (2017) Antioxidant and anti-inflammatory effects of DHK-medicated serum on high glucose-induced injury in endothelial cells. Molecular Medicine Reports 16:5, pages 7745-7751.
Crossref
Naoyuki Matsuda. (2016) Alert cell strategy in SIRS-induced vasculitis: sepsis and endothelial cells. Journal of Intensive Care 4:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.